| 000 | 01681 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515021206.0 | ||
| 264 | 0 | _c20060822 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a0363-9045 | ||
| 024 | 7 |
_a10.1080/03639040500519300 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Chen-Chao | |
| 245 | 0 | 0 |
_aDevelopment of near zero-order release dosage forms using three-dimensional printing (3-DP) technology. _h[electronic resource] |
| 260 |
_bDrug development and industrial pharmacy _cMar 2006 |
||
| 300 |
_a367-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 |
_aEphedrine _xadministration & dosage |
| 650 | 0 | 4 | _aHot Temperature |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aHypromellose Derivatives |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylcellulose _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPovidone _xchemistry |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xinstrumentation |
| 650 | 0 | 4 |
_aWater _xchemistry |
| 700 | 1 | _aTejwani Motwani, Monica R | |
| 700 | 1 | _aRoach, Willie J | |
| 700 | 1 | _aKay, Jennifer L | |
| 700 | 1 | _aYoo, Jaedeok | |
| 700 | 1 | _aSurprenant, Henry L | |
| 700 | 1 | _aMonkhouse, Donald C | |
| 700 | 1 | _aPryor, Timothy J | |
| 773 | 0 |
_tDrug development and industrial pharmacy _gvol. 32 _gno. 3 _gp. 367-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/03639040500519300 _zAvailable from publisher's website |
| 999 |
_c16164172 _d16164172 |
||